Recombinant Mouse ACE2 protein (rFc Tag)
Species
Mouse
Purity
>90 %, SDS-PAGE
Tag
rFc Tag
Activity
not tested
Cat no : Eg2834
Validation Data Gallery
Product Information
Purity | >90 %, SDS-PAGE |
Endotoxin | <0.1 EU/μg protein, LAL method |
Activity |
Not tested |
Expression | HEK293-derived Mouse ACE2 protein Gln18-Thr740 (Accession# Q8R0I0-1) with a rabbit IgG Fc tag at the C-terminus. |
GeneID | 70008 |
Accession | Q8R0I0-1 |
PredictedSize | 109.5 kDa |
SDS-PAGE | 110-130 kDa, reducing (R) conditions |
Formulation | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
Storage Conditions |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
ACE2 (Angiotensin-converting enzyme 2), also named as ACEH, is a zinc metalloprotease of the ACE family and a critical regulator of the reninangiotensin system. ACE2 has a more restricted tissue distribution than ACE, being found predominantly in the heart, kidneys, and testes although low levels have been detected in a variety of tissues. ACE2 has been shown to be a functional receptor of the human coronaviruses SARS-CoV and SARS-CoV-2. The expression level and expression pattern of human ACE2 in different tissues might be critical for the susceptibility, symptoms, and outcome of 2019-nCoV/SARS-CoV-2 infection. It can be used as a potential therapeutic target of SARS-CoV-2.
References:
1. Lambert DW, et al. (2005) J Biol Chem. 280(34):30113-9. 2. Hoffmann M, et al. (2020) Cell. 181(2):271-280.e8. 3. Cao Y, et al. (2020) Cell Discov. 6:11. 4. Zhang H, et al. (2020) Intensive Care Med. 46(4):586-590. 5. Warner FJ, et al. (2005) J Biol Chem. 280(47):39353-62.